Compare SXC & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXC | CATX |
|---|---|---|
| Founded | 1960 | 1983 |
| Country | United States | United States |
| Employees | 848 | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 555.4M | 497.9M |
| IPO Year | 2011 | 2018 |
| Metric | SXC | CATX |
|---|---|---|
| Price | $6.52 | $4.52 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $9.00 | ★ $12.11 |
| AVG Volume (30 Days) | ★ 1.1M | 1.0M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | ★ 7.54% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,600,300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.30 | N/A |
| 52 Week Low | $5.52 | $1.96 |
| 52 Week High | $9.82 | $6.16 |
| Indicator | SXC | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 53.18 | 51.98 |
| Support Level | $6.16 | $3.93 |
| Resistance Level | $6.90 | $4.63 |
| Average True Range (ATR) | 0.21 | 0.29 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 69.42 | 62.80 |
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.